| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 01/05/2006 | WO2006002438A2 Human monoclonal antibodies to fc gamma receptor i (cd64) |
| 01/05/2006 | WO2006002377A2 Optimized dosing with anti-cd4 antibodies for tolerance induction in primates |
| 01/05/2006 | WO2006002177A2 Interferon alpha receptor 1 antibodies and their uses |
| 01/05/2006 | WO2006002064A2 Antibody inhibiting stem cell factor activity and use for treatment of asthma |
| 01/05/2006 | WO2006002058A2 Treatment of autism |
| 01/05/2006 | WO2006002057A2 Treatment of acne |
| 01/05/2006 | WO2006000787A2 Antibodies against bacterial antigens and their use in the generation of immune responses against apoptotic cells |
| 01/05/2006 | WO2006000719A2 COG47 PROTEIN AND S100β GENE POLYMORPHISM |
| 01/05/2006 | WO2005071070A3 Substances directed against specific sequence essential for heparanase catalytic activity end uses thereof as heparanase inhibitors |
| 01/05/2006 | WO2005067708A3 Zebrafish model for autoimmune diseases |
| 01/05/2006 | WO2005066867A3 Modulators of cell-surface receptors of the ig-class |
| 01/05/2006 | WO2005063292A8 Heh4 molecules and uses thereof |
| 01/05/2006 | WO2005054499A3 Use of l-isoaspartyl methyltransferase as longevity marker in seeds |
| 01/05/2006 | WO2005044853A3 Anti-vegf antibodies |
| 01/05/2006 | WO2005030793A3 Antibodies which bind human cxcr3 |
| 01/05/2006 | WO2005028433A3 CRIPTO ANTAGONISM OF ACTIVIN AND TGF-β SIGNALING |
| 01/05/2006 | WO2004078146A3 Trans-membrane-antibody induced inhibition of apoptosis |
| 01/05/2006 | WO2004071441A3 Compositions and methods to modulate immune and inflammatory responses |
| 01/05/2006 | WO2004008946A3 Methods of diagnosing and treating pre-eclampsia or clamp |
| 01/05/2006 | WO2003087338A3 Her-2 receptor tyrosine kinase molecules and uses thereof |
| 01/05/2006 | WO2003016493A3 Transporters and ion channels |
| 01/05/2006 | US20060004188 Chemically reactive carbocyanine dyes incorporating an indolium ring moiety that is substituted at the 3-position by a reactive group or by a conjugated substance |
| 01/05/2006 | US20060004184 Method and device for detecting feline immunodeficiency virus |
| 01/05/2006 | US20060004019 Steroid sparing agents and methods of using same |
| 01/05/2006 | US20060003937 Urocortin-III and uses thereof |
| 01/05/2006 | US20060003934 Polypeptide; polyethylene glycolylated polypeptide; antidiabetic agents; side effect reduction |
| 01/05/2006 | US20060003916 Parathyroid hormone-related protein (PTHrP) specific antibodies for targeted treatment of kidney, liver and/or lung specic cell proliferative disorders; Antitumor agents |
| 01/05/2006 | US20060003445 Method and device for detecting feline immunodeficiency virus |
| 01/05/2006 | US20060003422 Method for the identification of substances mimicking mammal epitopes |
| 01/05/2006 | US20060003419 Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use |
| 01/05/2006 | US20060003418 Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use |
| 01/05/2006 | US20060003417 Polypeptide; polyethylene glycolylated polypeptide; antidiabetic agents; side effect reduction |
| 01/05/2006 | US20060003410 Oxidoreductase for use in identifying modulators for prevention and treatment of diabetes, obesity, dyslipidemia, coronary heart, inflammatory and cancer disorders |
| 01/05/2006 | US20060003380 Human tumor necrosis factor receptor TR-17 |
| 01/05/2006 | US20060003379 Smad6 and uses thereof |
| 01/05/2006 | US20060003378 Expressed by keratinocytes, wound-healing and chondrosarcoma tissue; nucleic acids comprising polynucleotide of given sequence; use in diagnostics and therapeutics |
| 01/05/2006 | US20060003355 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/05/2006 | US20060003346 Method for treating hepatitis |
| 01/05/2006 | US20060003334 Protein (poly)peptides libraries |
| 01/05/2006 | US20060002993 Genetic engineered protein; transgenic animal, used to elicit a humoral or cellular immune response |
| 01/05/2006 | US20060002948 Polypeptide isolated from Dermatophagoides; use of polypeptides, polynucleotides and/or antibodies in therapy and diagnosis of allergic disorders; genetic engineering |
| 01/05/2006 | US20060002945 Non-sensitive antigenic peptide derived from fc portion of the epsilon heavy chain of immunoglobulin-E for use in treatment and prevention of allergic disorders |
| 01/05/2006 | US20060002943 Compositions and methods for the treatment of tumor of hematopoietic origin |
| 01/05/2006 | US20060002942 Calicheamicin conjugates |
| 01/05/2006 | US20060002941 Compositions comprising immune response altering agents and methods of use |
| 01/05/2006 | US20060002939 Monoclonal and chimeric antibodies that bind to lipoteichoic acid of Gram positive bacteria. The antibodies also bind to whole bacteria and enhance phagocytosis and killing of the bacteria in vitro and enhance protection from lethal; light and heavy chains comprising complementarity determining regions |
| 01/05/2006 | US20060002937 Methods for treating conditions associated with MASP-2 dependent complement activation |
| 01/05/2006 | US20060002935 Tumor Necrosis Factor Receptor 1 antagonists and methods of use therefor |
| 01/05/2006 | US20060002933 Methods and materials for modulation of the immunosuppressive activity and toxicity of monoclonal antibodies |
| 01/05/2006 | US20060002931 Antibodies of angiogenesis inhibiting domains CD148 |
| 01/05/2006 | US20060002930 Treatment of disorders |
| 01/05/2006 | US20060002929 Monoclonal antibodies |
| 01/05/2006 | US20060002927 Use of anti-cd1 antibodies for the modulation of immune responses |
| 01/05/2006 | US20060002926 isolated and/or recombinant; characterized by high affinity binding of one or more chemokines, such as eotaxin, RANTES and/or MCP-3, and/or the ability to stimulate a (one or more) cellular response(s) (e.g., chemotaxis, exocytosis, release of one or more inflammatory mediators) |
| 01/05/2006 | US20060002925 Soluble ZcytoR14, anti-ZcytoR14 antibodies and binding partners and methods of using in inflammation |
| 01/05/2006 | US20060002924 Conjugate of notch signalling pathway modulators and their use in medical treatment |
| 01/05/2006 | US20060002923 Recombinant anti-osteopontin antibody and use thereof |
| 01/05/2006 | US20060002920 different epitopes are located within the binding domain of the natural ligand(s) of said receptor; first and second antigen-binding site binds to a different epitope on the same EGFR molecule; anticarcinogenicb antimetastasis agents |
| 01/05/2006 | US20060002892 Lectin-like transcript (LLTI); Natural killer cells; antitumor agents; quantitative analysis; human lectin transcription factor |
| 01/05/2006 | US20060002855 Targeted combination immunotherapy of cancer and infectious diseases |
| 01/05/2006 | US20060002854 Conjugate of therapeutic moiety linked to peptide having the amino acid sequence CGKRK, length < 400 residues, or a conservative variant or peptidomimetic; anticarcinogenic, -tumor agents; tissue-targeted therapy; side effect reduction; binds cognate receptor; angiogenesis inhibitors |
| 01/05/2006 | DE102004029470A1 Verfahren zur Bestimmung von Aggrekanase-Aktivitäten Method for determination of aggrecanase activity |
| 01/05/2006 | CA2570849A1 Optimized dosing with anti-cd4 antibodies for tolerance induction in primates |
| 01/05/2006 | CA2570823A1 Interferon alpha receptor 1 antibodies and their uses |
| 01/05/2006 | CA2568661A1 Human monoclonal antibodies to fc gamma receptor i (cd64) |
| 01/04/2006 | EP1612268A1 Receptor ligand VEGF-C |
| 01/04/2006 | EP1612266A2 Prostaglandin reductase |
| 01/04/2006 | EP1612263A1 PTH receptor and screening assay utilizing the same |
| 01/04/2006 | EP1612224A1 Novel monoclonal thyroid stimulating or blocking antibodies, peptide sequences corresponding to their variable regions, and their uses in diagnostic, preventive and therapeutic medicine |
| 01/04/2006 | EP1612219A1 Allergen from house-dust mites |
| 01/04/2006 | EP1612217A2 Immuno-reactive peptide CTL epitopes of human cytomegalovirus |
| 01/04/2006 | EP1611890A1 Methods for assessing and treating cancer |
| 01/04/2006 | EP1611887A2 Modulation of peroxisome proliferator-activated receptors |
| 01/04/2006 | EP1611250A2 Detection of urinary mesothelin-/megakaryocyte potentiating factor-related peptides for assessment of ovarian cancer |
| 01/04/2006 | EP1611156A2 Neoplasm specific antibodies and uses thereof |
| 01/04/2006 | EP1611155A2 Method and compositions for conversion of antibody activity |
| 01/04/2006 | EP1611154A1 Treatment of type 1 immune response-mediated inflammatory lung disease by modulation of ifn-gamma activity |
| 01/04/2006 | EP1610824A2 Modified aerolysin linked to a lung cancer binding agent and methods of use for treating lung cancer |
| 01/04/2006 | EP1610820A1 High concentration antibody and protein formulations |
| 01/04/2006 | EP1610818A1 Modified antibodies to prostate-specific membrane antigen and uses thereof |
| 01/04/2006 | EP1610757A2 Profiling conformational variants, antibody compositions and methods of using the same |
| 01/04/2006 | EP1610678A2 Antibodies and pharmaceutical compositions containing same useful for inhibiting activity of metalloproteins |
| 01/04/2006 | EP1509166A4 Method for improving body weight gain and feed conversion efficiency in animals |
| 01/04/2006 | EP1357941B1 Therapeutical use of anti-mag antibody for the treatment of ischemic stroke |
| 01/04/2006 | EP1311677B1 Regulation of human p2y1-like g protein-coupled receptor |
| 01/04/2006 | EP1250422B1 Myeloid colony stimulating factor and uses thereof |
| 01/04/2006 | EP1183390B1 METHODS FOR PREDICTING PREGNANCY OUTCOME IN A SUBJECT BY hCG ASSAY |
| 01/04/2006 | EP1169642B1 Complex formed by n-linked glycoproteins (siblings) and factor h |
| 01/04/2006 | EP0970243B1 Diagnosis and treatment of glaucoma |
| 01/04/2006 | EP0913405B1 Monoclonal antibody specific for prostaglandin d synthetase |
| 01/04/2006 | CN1717418A Antibody for the thyrotropin receptor and uses thereof |
| 01/04/2006 | CN1717417A Novel immunoadhesins for treating and prventing toxicity and pathogen-mediated diseases |
| 01/04/2006 | CN1717251A Peptide-based passive immunization therapy for treatment of atherosclerosis |
| 01/04/2006 | CN1715921A Use of human RGPR protein in preparing prostatic cancer diagnostic reagent kit |
| 01/04/2006 | CN1234730C Mouse antichloromycetin monoclonal antibody and its use |
| 01/04/2006 | CN1234728C Novel human lymphokine, its coding sequence and use |
| 01/04/2006 | CN1234725C High performance quick purifying method for preparing piecewise antibody |
| 01/03/2006 | US6982326 Allergenic proteins and peptides from Japanese cedar pollen |
| 01/03/2006 | US6982322 Monoclonal antibodies against human apoptosis inhibitory protein naip and method for assaying naip |
| 01/03/2006 | US6982321 Altered antibodies |